Irma Slavutsky

1.4k total citations
105 papers, 1.0k citations indexed

About

Irma Slavutsky is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, Irma Slavutsky has authored 105 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Genetics, 37 papers in Molecular Biology and 34 papers in Hematology. Recurrent topics in Irma Slavutsky's work include Chronic Lymphocytic Leukemia Research (34 papers), Acute Myeloid Leukemia Research (22 papers) and Genomic variations and chromosomal abnormalities (19 papers). Irma Slavutsky is often cited by papers focused on Chronic Lymphocytic Leukemia Research (34 papers), Acute Myeloid Leukemia Research (22 papers) and Genomic variations and chromosomal abnormalities (19 papers). Irma Slavutsky collaborates with scholars based in Argentina, Spain and United States. Irma Slavutsky's co-authors include Irene Larripa, Raimundo Bezares, Dorotea Fantl, Marina Narbaitz, Sakari Knuutila, José Mordoh, Jorge Arbelbide, Claudia Corrado, Alejandro Roisman and Juan Carlos Gómez and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Irma Slavutsky

101 papers receiving 998 citations

Peers

Irma Slavutsky
Barbara Czepulkowski United Kingdom
John H. Proffitt United States
A. A. Sandberg United States
Allen Coleman United States
Albert G. Tsai United States
Kathy M. Ensrud United States
Rodman Morgan United States
Jeffrey R. Shearstone United States
Barbara Czepulkowski United Kingdom
Irma Slavutsky
Citations per year, relative to Irma Slavutsky Irma Slavutsky (= 1×) peers Barbara Czepulkowski

Countries citing papers authored by Irma Slavutsky

Since Specialization
Citations

This map shows the geographic impact of Irma Slavutsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irma Slavutsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irma Slavutsky more than expected).

Fields of papers citing papers by Irma Slavutsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irma Slavutsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irma Slavutsky. The network helps show where Irma Slavutsky may publish in the future.

Co-authorship network of co-authors of Irma Slavutsky

This figure shows the co-authorship network connecting the top 25 collaborators of Irma Slavutsky. A scholar is included among the top collaborators of Irma Slavutsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irma Slavutsky. Irma Slavutsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Slavutsky, Irma, et al.. (2022). Survival analysis of transplant-eligible newly-diagnosed multiple myeloma patients harboring t(4;14), t(14;16), and/or del(17p) in the real-world setting. Current Problems in Cancer. 47(1). 100916–100916. 4 indexed citations
2.
Akkari, Yassmine, Linda B. Baughn, Adrian M. Dubuc, et al.. (2022). Guiding the global evolution of cytogenetic testing for hematologic malignancies. Blood. 139(15). 2273–2284. 47 indexed citations
3.
Arroyo, Daniela S., et al.. (2020). Increased Expression of Autophagy Protein LC3 in Two Patients With Progressing Chronic Lymphocytic Leukemia. Frontiers in Endocrinology. 11. 321–321. 6 indexed citations
4.
Slavutsky, Irma. (2017). Shelterin genes, germ line mutations and chronic lymphocytic leukemia. Translational Cancer Research. 6(1). 1 indexed citations
5.
Colado, Ana, María Belén Almejún, Enrique Podaza, et al.. (2016). The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients. Cancer Immunology Immunotherapy. 66(4). 461–473. 14 indexed citations
6.
Roisman, Alejandro, et al.. (2016). Genomic imbalances and microRNA transcriptional profiles in patients with mycosis fungoides. Tumor Biology. 37(10). 13637–13647. 13 indexed citations
7.
Bezares, Raimundo, et al.. (2015). Telomere shortening associated with increased genomic complexity in chronic lymphocytic leukemia. Tumor Biology. 36(11). 8317–8324. 19 indexed citations
8.
Arbelbide, Jorge, et al.. (2013). Expression profile of shelterin components in plasma cell disorders. Clinical significance of POT1 overexpression. Blood Cells Molecules and Diseases. 52(2-3). 134–139. 20 indexed citations
9.
Larripa, Irene, et al.. (2009). Alteraciones genéticas, inestabilidad genómica y cáncer en enfermedad celíaca. SHILAP Revista de lepidopterología. 39(1). 55–62. 1 indexed citations
10.
Arbelbide, Jorge, et al.. (2009). DNA methylation analysis of tumor suppressor genes in monoclonal gammopathy of undetermined significance. Annals of Hematology. 89(2). 191–199. 34 indexed citations
11.
Narbaitz, Marina, et al.. (2009). Analysis of telomere length in mantle cell lymphoma. European Journal Of Haematology. 83(5). 433–438. 9 indexed citations
12.
Slavutsky, Irma, et al.. (2008). Ag-NOR staining and satellite association in lymphoproliferative disorders. Hereditas. 115(3). 207–212.
13.
Narbaitz, Marina, et al.. (2006). Inversions of chromosomes 2 and 6 in mantle cell lymphoma. Cytogenetic, FISH, and molecular studies. Cancer Genetics and Cytogenetics. 167(2). 164–167. 4 indexed citations
15.
16.
Crivelli, Adriana, et al.. (2003). Telomere Length Study in Celiac Disease. The American Journal of Gastroenterology. 98(12). 2727–2731. 10 indexed citations
17.
Bianco, R., et al.. (2003). Structural aberrations of chromosomes 17 and 12 in chronic B‐cell disorders. European Journal Of Haematology. 71(6). 433–438. 2 indexed citations
18.
Slavutsky, Irma, et al.. (1998). Translocation t(1;10) (q21;q26) in a Case of Acute Nonlymphocytic Leukemia. Acta Haematologica. 99(2). 92–94. 2 indexed citations
19.
Guerra, Liliana N., José Mordoh, Irma Slavutsky, Irene Larripa, & Estela E. Medrano. (1989). Characterization of IIB‐MEL‐J: A New and Highly Heterogenous Human Melanoma Cell Line. Pigment Cell Research. 2(6). 504–509. 32 indexed citations
20.
Slavutsky, Irma, et al.. (1988). Heterochromatic variants and their association with neoplasias: V. Non-Hodgkin's lymphomas. Cancer Genetics and Cytogenetics. 31(2). 175–178. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026